by Leanne Talbot | Sep 24, 2021
Reporting from #ESMO2021 Can immunotherapy improve treatment of advanced #Neuroendocrine neoplasms? SELECT HERE TO READ REPORT. by Leanne Talbot | Sep 1, 2021
There are a number of treatments available for Neuroendocrine Cancer – but your treatment should be based on your Neuroendocrine Cancer, your general health and your informed choice. You can find out more about treatments in Neuroendocrine Cancer here ➡️... by Leanne Talbot | Jul 26, 2021
NCUK Launches their Bridging the Gap Campaign, the second of our three ‘Gap’ Campaigns. What is the BRIDGING the Gap campaign? We are working towards and obtaining a dedicated Neuroendocrine care pathway to provide equitable, holistic, joined up care for... by Leanne Talbot | Jul 7, 2021
Taking part in a clinical trial can be a big commitment – with more travel to the hospital than normal, extra tests, scans, and an increased number of appointments. Whether you decide to take part in a clinical trial or not, you should receive the highest standard... by Leanne Talbot | Jun 29, 2021
Neuroendocrine Cancer UK are Delighted to be here at the ‘Do you C Us’ Parliamentary event driven by Cancer 52, and chaired by Paul Bristow MP. Raising awareness of the issues around Rare and Uncommon Cancers. Other speakers including Jane Lyons (CEO)... 
